Table 2

Grade of recommendation

Guideline nameScope and purpose (%)Stakeholder involvement (%)Rigour of development (%)Clarity and presentation (%)Applicability (%)Editorial independence (%)Weighted Kappa Scores (Quadratic)95% CI
ARA 20101 753110672500.740.56 to 0.92
Aguado et al 20093 7228247229580.760.62 to 0.90
CDC 20169 8989817577830.29−0.14 to 0.71
WHO 201510 9794888992880.670.27 to 1.00
Beglinger et al 200715 754223672500.720.54 to 0.91
Cantini et al 201516 8953558956380.800.63 to 0.97
Doherty et al 200817 9244758671580.550.19 to 0.91
Duarte et al 201218 864431835200.670.46 to 0.89
Fonseca et al 200819 927273866040.740.53 to 0.95
Hodkinson
et al 201320
8383567571250.00−0.27 to 0.27
Kavanagh
et al 200821
643329671500.610.39 to 0.82
Keith et al 201422 8342455019420.610.27 to 0.92
Koike et al 200723 7833285610290.410.08 to 0.75
Lichauco et al 200624 896967786500.640.27 to 1.00
Mir Viladrich
et al 201626
8142297540420.660.44 to 0.88
Mok et al 201127 6936285327330.530.24 to 0.82
Nordgaard-Lassen et al 201228 783948643500.750.60 to 0.90
Salmon 200225 72421364000.760.55 to 0.97
BTS 200529 9269918971630.32−0.05 to 0.70
Smith et al 200930 9461808365750.770.51 to 1.00
Solovic et al 201031 6933358144380.660.41 to 0.92
Carrascosa et al 201632 6742466121830.710.56 to 0.87
Bumbacea et al 201233 6944438140670.480.13 to 0.84
KDIGO 200934 10078677565920.21−0.07 to 0.48
Meiji et al 201435 6425287225380.670.43 to 0.89
EBPG 200236 8667688977750.18−0.05 to 0.41
Subramanian 201337 7542427854420.31−0.10 to 0.71
Tomblyn et al 200938 8158436935170.440.15 to 0.74
Pozniak et al 201139 814238645600.730.51 to 0.95
SA 201040 781910786900.910.85 to 0.98
Santin et al 201641 9258748367880.730.49 to 0.97
Al Jahdali et al 201042 835832754600.580.35 to 0.81
ECDC 201143 7231336929170.410.14 to 0.67
Mazurek et al 201044 787271726080.570.33 to 0.81
Taylor et al (CDC 2005) 45 754428583800.260.09 to 0.47
CTC 200846 8350526940460.290.01 to 0.58
Japanese Society for Tuberculosis 201447 561126676000.670.52 to 0.82
NICE 201648 10097939269830.520.09 to 0.96
  • ARA, Australian Rheumatological Association; BTS, British Thoracic Society; CDC, centre for disease control; CTC, Canadian Tuberculosis Committee; EBPG, European Best Practice Guideline Expert Group on Renal Transplantation; ECDC, European Centre for Disease Prevention and Control; KDIGO, Kidney Disease Improving Global Outcomes; NICE, National Institute for Health and Care Excellence; SA, South Africa.